HyGen Pharmaceuticals is proud to announce that Omid Ghobadi, Senior Vice President, has been elected to the Board of Directors of the HDA – Healthcare Distribution Alliance, representing HyGen’s continued commitment to advancing pharmaceutical distribution, access, and innovation across the industry.
The HDA Board plays a vital role in shaping the strategic direction of the pharmaceutical supply chain in the United States, and Omid’s appointment is a recognition of HyGen’s growing leadership and influence in the sector.
With deep experience in pharmaceutical commercialization and a passion for equitable healthcare access, Omid brings a unique perspective to the Board’s ongoing efforts to strengthen supply chain resilience, policy advocacy, and member collaboration.
“We are honored to have Omid represent HyGen at the HDA Board level,” said Gary Prester, Chairman, HyGen Pharmaceuticals. “Omid’s election reflects both his personal dedication and HyGen’s mission to be a trusted, values-driven partner to healthcare providers and patients nationwide.”
As a member of the Board, Omid will work alongside distribution and manufacturer leaders to help guide the HDA’s initiatives around regulatory policy, industry best practices, and public-private partnerships, all in service of a stronger, more responsive healthcare system.
